Algae-encoded biopharmaceuticals

by admin | Jun 25, 2022 | Publications

See the cover and read more

Lumen Bioscience Hacks Spirulina to Generate Biologics

by admin | May 17, 2022 | Press Release

Read more

BARDA and Lumen Bioscience partner on a rapidly scalable novel manufacturing platform to develop an intranasal antibody cocktail to treat COVID-19

by admin | Apr 27, 2022 | Press Release

Read more

When Free Markets Fail… and Maybe You Die

by admin | Apr 25, 2022 | Press Release

Read more

Moving closer to the patient

by admin | Apr 18, 2022 | News

By Jake Siegel and Brian Finrow Today we announced several milestones in the clinical development of LMN-201, Lumen’s orally delivered biologic cocktail to prevent C. difficile infection (CDI). The big headline: the FDA has greenlit Phase 2 studies of LMN-201. Soon we...